Thousands of men battling prostate cancer are set to gain access to a life-extending drug on the NHS following a significant ...

The UCLA trial is currently enrolling patients.

Q. You recently wrote that testosterone does not increase the risk for heart attacks. But you overlooked the real risk of ...

A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a ...

For more than 40 years, Florida Cancer Specialists & Research Institute (FCS) has embraced innovation to deliver world-class care and drive the dramatic transformation of oncology care through its ...

Advanced imaging, particularly PSMA PET scans, enhances detection of microscopic disease, allowing for more precise treatment ...

All My Children alum Colin Egglesfield detailed his decision to initially keep his testicular cancer battle a secret when he ...

Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...

The second annual report from the National Cancer Database (NCDB) of the American College of Surgeons (ACS) documents a ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.